Core & Main (CNM) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
10 Dec, 2025Executive summary
Net sales for Q3 FY2025 rose 1.2% year-over-year to $2,062 million, driven by acquisitions and strong sales initiatives, with organic volumes and prices flat.
Municipal and non-residential markets remained strong, offsetting softness in residential, especially in Sunbelt regions and lot development.
Strategic investments in product lines, geographic expansion, and M&A, including entry into the Canadian market, are driving long-term growth.
Product initiatives like fusible HDPE, treatment plant solutions, and geosynthetics achieved double-digit growth; metering products saw high single-digit growth.
$30 million in annualized cost savings implemented, with 4% reduction in non-sales roles.
Financial highlights
Q3 net sales up 1.2% to $2,062 million; gross profit up 3.3% to $561 million; gross margin improved by 60 bps year-over-year to 27.2%.
Adjusted EBITDA was $274 million, down 1.1% year-over-year; adjusted EBITDA margin declined 30 bps to 13.3%.
Adjusted Diluted EPS rose 3.5% to $0.89; diluted EPS up 4.3% to $0.72.
Operating cash flow reached $271 million in Q3, nearly 100% conversion from adjusted EBITDA.
Free cash flow yield over the last 12 months was 5.6% of market capitalization.
Outlook and guidance
Full-year net sales guidance reaffirmed at $7,600–$7,700 million, with adjusted EBITDA of $920–$940 million and operating cash flow of $550–$610 million.
Net sales growth projected at 4–5%, excluding a 2% headwind from one fewer selling week.
End market volumes expected to be flat to slightly down, with residential down double digits, municipal up low to mid-single digits, and non-residential flat.
Gross margin expected to improve year-over-year, with continued private label and sourcing initiatives.
On track for 2–4% organic above-market growth.
Latest events from Core & Main
- Net sales up 11% to $1.74B, but margins narrowed and net income declined on higher costs.CNM
Q1 202531 Jan 2026 - Record Q2 sales from acquisitions offset by lower income and reduced outlook amid market headwinds.CNM
Q2 202522 Jan 2026 - Record Q3 sales, raised outlook, and strong cash flow highlight robust growth and execution.CNM
Q3 202512 Jan 2026 - Record sales and EBITDA in FY24; 2025 outlook strong with growth and stable margins.CNM
Q4 202526 Dec 2025 - Record sales, new leadership, and strong governance mark this year's proxy highlights.CNM
Proxy Filing1 Dec 2025 - Virtual annual meeting to vote on directors, auditor, and executive pay, all board-backed.CNM
Proxy Filing1 Dec 2025 - Record Q1 sales up 9.8%–10%, margin gains, and FY2025 outlook reaffirmed.CNM
Q1 202610 Nov 2025 - Q2 sales rose 6.6%–7% with strong municipal demand, but 2025 guidance was lowered on higher costs.CNM
Q2 202610 Sep 2025